Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Positive Regulator Molecules02:39

Positive Regulator Molecules

5.7K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.7K
Tumor Progression02:07

Tumor Progression

6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Dual-Functional Luminescent MOF Sensor for Phenylmethanol Molecule and Tb<sup>3+</sup> Cation.

Inorganic chemistry·2018
Same author

The Development and Test of a Sensor for Measurement of the Working Level of Gas-Liquid Two-Phase Flow in a Coalbed Methane Wellbore Annulus.

Sensors (Basel, Switzerland)·2018
Same author

A Thioflavin T-induced G-Quadruplex Fluorescent Biosensor for Target DNA Detection.

Analytical sciences : the international journal of the Japan Society for Analytical Chemistry·2018
Same author

A metal-organic framework derived hierarchical nickel-cobalt sulfide nanosheet array on Ni foam with enhanced electrochemical performance for supercapacitors.

Dalton transactions (Cambridge, England : 2003)·2018
Same author

Functional analysis of a type 2C protein phosphatase gene from Ammopiptanthus mongolicus.

Gene·2018
Same author

[Inversive LISS plate in treating intertrochanteric and subtrochanteric fractures combined with femoral shaft fractures].

Zhongguo gu shang = China journal of orthopaedics and traumatology·2018

Related Experiment Video

Updated: Sep 9, 2025

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

13.9K

Recent progress in the use of periplocin, periplocymarin and periplogenin in cancer treatment.

Xin Sun1,2, Xiao-Wei Shi1, Lei Han2

  • 1Medical College, Linyi University, Linyi 276000, Shandong Province, China.

World Journal of Clinical Oncology
|September 3, 2025
PubMed
Summary

Periplocin, periplocymarin, and periplogenin from Cortex Periplocae inhibit cancer cell proliferation and induce apoptosis. These cardiac glycosides target key cell cycle and apoptosis pathways, showing potential as anticancer agents.

Keywords:
Cancer therapyCortex PeriplocaePeriplocinPeriplocymarinPeriplogenin

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.1K
Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.5K

Related Experiment Videos

Last Updated: Sep 9, 2025

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

13.9K
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.1K
Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.5K

Area of Science:

  • Pharmacology
  • Natural Products Chemistry
  • Cancer Biology

Background:

  • Cortex Periplocae contains active components like periplocin, periplocymarin, and periplogenin.
  • Periplocin is a cytotoxic alpha cardiac glycoside; periplocymarin is derived from it, and periplogenin is its basic unit.
  • These compounds possess unique pharmacological activities relevant to cancer treatment.

Purpose of the Study:

  • To review the anticancer effects of periplocin, periplocymarin, and periplogenin.
  • To explore the antitumor mechanisms of these cardiac glycosides.
  • To highlight their potential in cancer therapy.

Main Methods:

  • Literature review focusing on preclinical and mechanistic studies.
  • Analysis of signaling pathways modulated by the glycosides.
  • Investigation of effects on cell cycle regulation and apoptosis.

Main Results:

  • These glycosides hinder cancer cell proliferation by regulating cell cycle proteins.
  • They induce cancer cell apoptosis via endogenous and exogenous pathways.
  • Modulation of retinoblastoma and p53 signaling pathways is a key mechanism.

Conclusions:

  • Periplocin, periplocymarin, and periplogenin demonstrate significant antitumor potential.
  • Their mechanisms involve cell cycle arrest and apoptosis induction.
  • Further research into these compounds could lead to novel cancer treatments.